A Multicenter Cross-Sectional Study and Systematic Review of Necrobiotic Xanthogranuloma With Proposed Diagnostic Criteria

Authors:

Abstract
Necrobiotic xanthogranuloma (NXG) is a non–Langerhans cell histiocytosis first described by Kossard and Winkelmann1 in 1980. It is typically associated with paraproteinemia attributable to plasma-cell dyscrasias or lymphoproliferative disorders.2 In addition to serving as a skin sign of systemic disease, NXG may result in cosmetic disfigurement. Extracutaneous involvement including the eye, heart, gastrointestinal tract, liver, and lung may result in organ dysfunction and death.1,3-5 Clinically, yellow-to-orange papules, plaques, and/or nodules in a periorbital distribution are classic; however, other morphological characteristics and sites have been described.6 Histopathologically, NXG demonstrates palisading granulomas with lymphoplasmacytic infiltrate and zones of necrobiosis. Cholesterol clefts and Touton or large, bizarre foreign body giant cells are other classical features.6 The pathogenesis of NXG remains unknown; however, a role for paraprotein-lipoprotein interaction has been hypothesized.7,8 Evaluation of 12 skin-biopsy specimens by Wood et al9 in 2009 found no evidence to support a monoclonal plasma-cell proliferation within the inflammatory infiltrate.

This publication has 160 references indexed in Scilit: